Dr Abeer Shabaan
Queen Elizabeth Hospital Birmingham & University of Birmingham
Dr Shaaban is a specialist breast pathologist at Queen Elizabeth Hospital Birmingham and Honorary Senior Lecturer at the University of Birmingham. She is Breast Pathology Clinical Advisor for West Midlands, Member of Big 18 group, Lead of NCRI CM-PATH Workstream 2 (clinical trials) and member of the International Committee of the Royal College of Pathologists.
She completed her PhD in molecular pathology at the University of Liverpool, did her pathology training at the West Midlands and Yorkshire regions before working as consultant pathologist in Leeds then Birmingham. She has led and contributed to a number of breast research studies and breast cancer trials and
published over 100 papers in the field. Dr Shaaban was member of the NCRI breast CSG and chair of the Translational Subgroup of the NCRI Breast Clinical Studies Group.
Breast Pathology: Assessing tumour response to neoadjuvant chemotherapy and endocrine therapy– Pathological considerations
The seminar will cover issues related to the multidisciplinary approach and pathological handling of neoadjuvant chemotherapy specimens, methods of histological assessment, importance of radiological correlation and recent developments including tumour bed biopsies.
EVEN MORE SEMINARS
Professor Farzin Farzaneh King’s College London
Advanced Therapy Medicinal Products (ATMPs) for achievement of deeper and longer lasting immune mediated cancer remission
Luca Boldrini Università Cattolica del Sacro Cuore, Roma, Italia
Radiomics applications rectal cancer: the MRIdian perspective
Prof. András SZÁSZ St. Istvan University
Modulated electrohyperthermia (mEHT) for advanced malignant tumors
Professor Hisham Mehanna InHANSE, Institute of Cancer and Genomic Sciences, University of Birmingham
Clinical trials that change patient care and the lessons learnt
Dr Sileida Oliveros GenesisCare
Surface-Guided Radiotherapy and Optimal Breast Cancer Treatment